ÂÜÀòÂÒÂ×

Jennifer Kolucki is a seasoned professional in analytical development and business management, currently serving as a Business Development Manager at Piramal Pharma Solutions since January 2024. Previously, Jennifer held the position of Associate Director of Analytical Development at Sage Therapeutics from January 2021 to September 2023, where responsibilities included managing analytical activities at CMOs and CROs to support Phase 2 through process validation efforts, as well as leading analytical reviews for NDA submissions of ZurzuvaeTM. Prior roles include Associate Director and Head of Analytical Development at Catabasis Pharmaceuticals, where management of CROs and CMOs for method development and validation was key, and various positions at Chemic Laboratories, culminating in the role of Analytical Chemist II. Jennifer holds a Bachelor of Science degree in Chemistry from Boston College, earned between 2001 and 2005.